A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Completed · Phase 2 · Has a placebo group

Conditions studied: Psoriasis

In brief

This study will investigate the safety, efficacy and pharmacokinetics of R3421 in patients with moderate to severe chronic plaque psoriasis. Patients will be randomized to one of 3 treatment groups to receive once daily oral treatment with a)R3421 20mg, b)R3421 120mg, or c)placebo. The anticipated time on study treatment is \<3 months, and the target sample size is \<100 individuals.

Key facts

Study ID

NCT00504270

Run by

Hoffmann-La Roche

People needed

66

Starts

2007-07-01

Expected to finish

2009-09-01

Last updated by the study team

2016-11-02

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult patients, 18-70 years of age;
• medically stable, moderate to severe chronic plaque psoriasis.

You may not qualify if…

• any skin condition which may interfere with evaluation of the effect of study medication on plaque lesions;
• confounding or concomitant condition or treatment.

Where it is running

• Study site — Hot Springs, Arkansas, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Santa Monica, California, United States
• Study site — Alpharetta, Georgia, United States
• Study site — East Windsor, New Jersey, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — New York, New York, United States
• Study site — New York, New York, United States
• Study site — Stony Brook, New York, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Providence, Rhode Island, United States
• Study site — Nashville, Tennessee, United States
• Study site — Galveston, Texas, United States
• Study site — San Antonio, Texas, United States
• Study site — Webster, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.